US2620371045 - Common Stock

**DRQ** gets a fundamental rating of **4** out of 10. The analysis compared the fundamentals against 65 industry peers in the **Energy Equipment & Services** industry. **DRQ** has a great financial health rating, but its profitability evaluates not so good. **DRQ** is valied quite expensively at the moment, while it does show a decent growth rate.

In the past year **DRQ** has reported negative net income.

In the past year **DRQ** had a positive cash flow from operations.

The reported net income has been mixed in the past 5 years: **DRQ** reported negative net income in multiple years.

In multiple years **DRQ** reported negative operating cash flow during the last 5 years.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -2.12% | ||

ROE | -2.53% | ||

ROIC | 0.12% |

ROA(3y)-4.28%

ROA(5y)-3.07%

ROE(3y)-4.81%

ROE(5y)-3.45%

ROIC(3y)N/A

ROIC(5y)N/A

The **Operating Margin** of **DRQ** (**0.30%**) is worse than **81.54%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 0.3% | ||

PM (TTM) | N/A | ||

GM | 27.53% |

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.44%

GM growth 5Y-1.51%

The number of shares outstanding for **DRQ** has been reduced compared to 5 years ago.

Compared to 1 year ago, **DRQ** has a worse debt to assets ratio.

The **Altman-Z score** of **DRQ** (**4.72**) is better than **92.31%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0 | ||

Debt/FCF | 0 | ||

Altman-Z | 4.72 |

ROIC/WACC0.01

WACC9.11%

A Current Ratio of **5.35** indicates that **DRQ** has no problem at all paying its short term obligations.

The **Current ratio** of **DRQ** (**5.35**) is better than **95.38%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 5.35 | ||

Quick Ratio | 3.79 |

The **Revenue** has been growing slightly by **1.97%** on average over the past years.

EPS 1Y (TTM)46.43%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-6100%

Revenue 1Y (TTM)19.93%

Revenue growth 3Y5.13%

Revenue growth 5Y1.97%

Sales Q2Q%21.39%

Based on estimates for the next years, **DRQ** will show a very strong growth in **Earnings Per Share**. The EPS will grow by **67.14%** on average per year.

Based on estimates for the next years, **DRQ** will show a quite strong growth in **Revenue**. The Revenue will grow by **12.73%** on average per year.

EPS Next Y396.27%

EPS Next 2Y176.69%

EPS Next 3Y116.97%

EPS Next 5Y67.14%

Revenue Next Year20.5%

Revenue Next 2Y14.38%

Revenue Next 3Y10.65%

Revenue Next 5Y12.73%

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

Based on the **Price/Forward Earnings** ratio, **DRQ** is valued expensively inside the industry as 83.08% of the companies are valued cheaper.

When comparing the **Price/Forward Earnings** ratio of **DRQ** to the average of the S&P500 Index (**19.93**), we can say **DRQ** is valued inline with the index average.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | 21.94 |

Compared to the rest of the industry, the **Price/Free Cash Flow** ratio of **DRQ** is on the same level as its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 26.06 | ||

EV/EBITDA | 12.87 |

The low **PEG Ratio(NY)**, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y176.69%

EPS Next 3Y116.97%

No dividends for **DRQ**!.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

**DRIL-QUIP INC**

NYSE:DRQ (6/12/2024, 2:09:49 PM)

**18.615**

**+0.21 (+1.17%) **

Chartmill FA Rating

GICS SectorEnergy

GICS IndustryGroupEnergy

GICS IndustryEnergy Equipment & Services

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap640.73M

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | 21.94 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -2.12% | ||

ROE | -2.53% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 0.3% | ||

PM (TTM) | N/A | ||

GM | 27.53% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.43

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 5.35 | ||

Quick Ratio | 3.79 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)46.43%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y396.27%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)19.93%

Revenue growth 3Y5.13%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y